Search

everythinglearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

CS12192 effectively treats alopecia areata with better safety than current options.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Researchers made new compounds that could potentially be developed into anticancer drugs.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Compound 7p shows strong potential as an anticancer agent.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

JAK inhibitors show promise for treating various skin diseases.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Baricitinib can cause excessive hair growth.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.